BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21527366)

  • 1. [Brain metastasis of breast tumors and blood brain barrier].
    DiƩras V; Pierga JY
    Bull Cancer; 2011 Apr; 98(4):385-9. PubMed ID: 21527366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of metastasis to a sanctuary site.
    Palmieri D; Chambers AF; Felding-Habermann B; Huang S; Steeg PS
    Clin Cancer Res; 2007 Mar; 13(6):1656-62. PubMed ID: 17363518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
    Tomasello G; Bedard PL; de Azambuja E; Lossignol D; Devriendt D; Piccart-Gebhart MJ
    Crit Rev Oncol Hematol; 2010 Aug; 75(2):110-21. PubMed ID: 20004109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.
    Gabos Z; Sinha R; Hanson J; Chauhan N; Hugh J; Mackey JR; Abdulkarim B
    J Clin Oncol; 2006 Dec; 24(36):5658-63. PubMed ID: 17102066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.
    Heitz F; Harter P; Lueck HJ; Fissler-Eckhoff A; Lorenz-Salehi F; Scheil-Bertram S; Traut A; du Bois A
    Eur J Cancer; 2009 Nov; 45(16):2792-8. PubMed ID: 19643597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heading in a new direction: drug permeability in breast cancer brain metastasis.
    Sledge GW
    Clin Cancer Res; 2010 Dec; 16(23):5605-7. PubMed ID: 21045085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNS metastasis: an old problem in a new guise.
    Aragon-Ching JB; Zujewski JA
    Clin Cancer Res; 2007 Mar; 13(6):1644-7. PubMed ID: 17363516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain metastases as late breast cancer relapse. Single institution experience and review of the literature.
    Tomasevic Z; Radosevic-Jelic Lj; Jovanovic D; Milovanovic Z; Tomasevic ZM; Jelic S; Borojevic N
    J BUON; 2009; 14(2):225-8. PubMed ID: 19650170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer brain metastases.
    Cheng X; Hung MC
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):635-43. PubMed ID: 17717635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the editor. Women with HER2-positive metastatic breast cancer have significantly longer survival after diagnosis of brain metastasis(BM) than those with HER2-negative disease.
    Kilickap S; Arslan C
    Am J Clin Oncol; 2009 Apr; 32(2):226. PubMed ID: 19346820
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple-negative breast cancer and brain metastases.
    Sait B; Cinar E; Altundag K
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):84. PubMed ID: 19751969
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention strategies for brain metastases from HER2-positive breast cancer].
    Le Tourneau C
    Bull Cancer; 2011 Apr; 98(4):445-9. PubMed ID: 21540148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of metastatic spread in triple-negative breast cancer.
    Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
    Breast Cancer Res Treat; 2009 May; 115(2):423-8. PubMed ID: 18543098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
    Yonemori K; Tsuta K; Ono M; Shimizu C; Hirakawa A; Hasegawa T; Hatanaka Y; Narita Y; Shibui S; Fujiwara Y
    Cancer; 2010 Jan; 116(2):302-8. PubMed ID: 19937674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the prognosis of breast cancer patients with brain metastases.
    Saip P; Cicin I; Eralp Y; Kucucuk S; Tuzlali S; Karagol H; Aslay I; Topuz E
    Breast; 2008 Oct; 17(5):451-8. PubMed ID: 18455400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
    Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
    Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of patients with triple-negative breast cancer and brain metastasis.
    Venkitaraman R; Joseph T; Dhadda A; Chaturvedi A; Upadhyay S
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):729-30. PubMed ID: 19643588
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the organ microenvironment in brain metastasis.
    Fidler IJ
    Semin Cancer Biol; 2011 Apr; 21(2):107-12. PubMed ID: 21167939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER-2 protein overexpression in metastatic breast carcinoma found at autopsy.
    Kyoda S; Kinoshita S; Takeyama H; Uchida K; Morikawa T
    Jpn J Clin Oncol; 2008 Nov; 38(11):743-7. PubMed ID: 18836203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.